Robert Eno
Präsident bei HEARTBEAM, INC.
Vermögen: - $ am 30.04.2024
Profil
Robert P.
Eno is currently the President at HeartBeam, Inc. Prior to his current position, he held various roles in different companies.
He was the Chief Executive Officer at Preview Medical, Inc. He also worked as a Marketing Manager at Guidant Corp.
from 1994 to 2000.
Additionally, he served as the VP-Global Marketing & International Sales at OptiMedica Corp., Senior Vice President-Marketing at HeartFlow, Inc., Vice President-Sales & Marketing at Avantec Vascular Corp., and Vice President-Marketing at NeoGuide Systems, Inc. Mr. Eno completed his undergraduate studies at Stanford University and obtained an MBA from Stanford Graduate School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HEARTBEAM, INC.
-.--% | 31.12.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Robert Eno
| Unternehmen | Position | Beginn |
|---|---|---|
| HEARTBEAM, INC. | Präsident | 18.01.2023 |
Ehemalige bekannte Positionen von Robert Eno
| Unternehmen | Position | Ende |
|---|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Vertrieb & Marketing | 01.01.2000 |
Preview Medical, Inc.
 Preview Medical, Inc. Packaged SoftwareTechnology Services Preview Medical, Inc. is a company that specializes in prostate cancer diagnosis and treatment. Preview Medical is based in Longmont, CO. The company has developed a system called Claricore ® which uses spectroscopy and an AI algorithm to classify prostate tissue as benign or suspicious. In a multi-center study, Claricore ® was shown to have high accuracy in classifying tissue. The company also offers a mapping system that uses spectroscopy to create a precise 3D map of the cancer, allowing for focal therapy procedures that treat the cancer while sparing healthy prostate tissue. | Vorstandsvorsitzender | - |
HeartFlow, Inc.
 HeartFlow, Inc. Packaged SoftwareTechnology Services HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA. | Vertrieb & Marketing | - |
OptiMedica Corp.
 OptiMedica Corp. Medical SpecialtiesHealth Technology OptiMedica Corp. manufactures medical devices. It is a ophthalmic device company dedicated to developing technologies that improve patient outcomes. It focuses in the cataract therapeutic area. The company was founded in 2004 and is headquartered in Sunnyvale, CA. | Vertrieb & Marketing | - |
Avantec Vascular Corp.
 Avantec Vascular Corp. Medical SpecialtiesHealth Technology Avantec Vascular Corp. provides treatment solutions. It also manufactures medical instrument and equipment used in interventional cardiology. The company was founded in 1999 and is headquartered in Sunnyvale, CA. | Vertrieb & Marketing | - |
Ausbildung von Robert Eno
| Stanford University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEARTBEAM, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
OptiMedica Corp.
OptiMedica Corp. Medical SpecialtiesHealth Technology OptiMedica Corp. manufactures medical devices. It is a ophthalmic device company dedicated to developing technologies that improve patient outcomes. It focuses in the cataract therapeutic area. The company was founded in 2004 and is headquartered in Sunnyvale, CA. | Health Technology |
HeartFlow, Inc.
HeartFlow, Inc. Packaged SoftwareTechnology Services HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA. | Technology Services |
Avantec Vascular Corp.
Avantec Vascular Corp. Medical SpecialtiesHealth Technology Avantec Vascular Corp. provides treatment solutions. It also manufactures medical instrument and equipment used in interventional cardiology. The company was founded in 1999 and is headquartered in Sunnyvale, CA. | Health Technology |
NeoGuide Systems, Inc.
 NeoGuide Systems, Inc. Medical SpecialtiesHealth Technology NeoGuide Systems, Inc. develops robotic endoscopic technology for the area of Natural Orifice Transluminal Endoscopic Surgery. Its technology is used in colonoscopy application to provide access to abdominal and thoracic cavities. The company was founded by Amir Belson and Matt Ohline on December 12, 2000 and is headquartered in Foster City, CA. | Health Technology |
Preview Medical, Inc.
Preview Medical, Inc. Packaged SoftwareTechnology Services Preview Medical, Inc. is a company that specializes in prostate cancer diagnosis and treatment. Preview Medical is based in Longmont, CO. The company has developed a system called Claricore ® which uses spectroscopy and an AI algorithm to classify prostate tissue as benign or suspicious. In a multi-center study, Claricore ® was shown to have high accuracy in classifying tissue. The company also offers a mapping system that uses spectroscopy to create a precise 3D map of the cancer, allowing for focal therapy procedures that treat the cancer while sparing healthy prostate tissue. | Technology Services |
